Tag: #Global Trends

A combined therapeutic regimen engineered by Moderna and Merck & Co. has demonstrated significant long-term clinical efficacy, reducing the risk... Read more

The U.S. Food and Drug Administration (FDA) has announced plans to convene a panel of independent external experts next month... Read more

A competitive pricing strategy implemented for oral obesity medications developed by Novo Nordisk and Eli Lilly is altering the U.S.... Read more

Biopharmaceutical multinational Gilead Sciences and the World Health Organization (WHO) have formalized an expanded global health covenant aimed at eliminating... Read more

At the ASCO 2026 annual meeting, a comprehensive clinical update from the alliance between Merck & Co. and Kelun-Biotech has... Read more

Biopharmaceutical multinational Gilead Sciences has expanded its strategic manufacturing partnership with South Korean producer Yuhan, finalizing an active pharmaceutical ingredient... Read more

Global biotechnology leader Amgen has finalized a structured executive succession plan following the announced retirement of its Chief Financial Officer... Read more

Privately held biotechnology innovator Mentari Therapeutics has entered into a definitive, all-stock merger agreement with InMed Pharmaceuticals (NASDAQ: INM). The... Read more